We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Obama Touts Generic Biologics To Lower Drug Costs

Law360 (February 26, 2009, 12:00 AM EST) -- In an effort to cut down prescription drug costs for both private citizens and the federal government, President Obama is pushing for the creation of a pathway to get generic biologic drugs to the market.

In the opening remarks of his budget, the president said that the ideal mechanism would be modeled on the 1984 Hatch-Waxman Act, which allows generic drug companies to provide bioequivalence studies to the U.S. Food and Drug Administration rather than perform costly and time-consuming clinical trials but also provides exclusivity periods...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.